Home > Insider Trading > Filing (0001209191-16-142415)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437786	Immune Design Corp.	IMDZ	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1182464	V David Goeddel	1700 Owens Street, Suite 500 San Francisco CA 94158	No	No	Yes	No
1347769	P L Group Column	1700 Owens Street, Suite 500 San Francisco CA 94158	No	No	Yes	No
1600420	Column Group Ii, Lp	1700 Owens Street, Suite 500 San Francisco CA 94158	No	No	Yes	No
1614627	Column Group Gp, Lp	1700 Owens Street, Suite 500 San Francisco CA 84158	No	No	Yes	No
1645333	Column Group Ii Gp, Lp	1700 Owens Street, Suite 500 San Francisco CA 94158	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-09-20	800,000	$6.25	3,961,942	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

the purchase of shares by The Column Group II, LP ("TCG II LP") in the follow-on offering of Common Stock of Immune Design Corp. that closed on September 20, 2016.
Includes shares directly held by TCG II LP and The Column Group, LP ("TCG LP"). The Column Group II GP, LP ("TCG II GP"), as the general partner of TCG II LP, has voting and dispositive power with respect to certain of the shares. The Column Group GP, LP ("TCG GP"), as the general partner of TCG LP, has voting and dispositive power with respect to certain of the shares. The individual managing partners of both TCG II GP and TCG GP are Peter Svennilson and David Goeddel, who may be deemed to have shared voting and dispositive power with respect to the shares. Each individual managing partner disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest in such shares.